NEW YORK (GenomeWeb News) – Seoul-based DNA Link will provide Roche NimbleGen's sequence capture technology as a service in Korea through a coupled offering that includes 454 Life Sciences' sequencing technology, Roche said today.

The Certified Service Provider status enables DNA Link to provide NimbleGen's Titanium Optimized Sequence Capture along with the 454 sequencing, the company said. The sequence capture method is used for genomic enrichment and uses NimbleGen's 385K Arrays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.